THE THESIS

The year 2045 sits at the intersection of two massive forces. It marks a century since the post-war order built the financial system we still live inside. And it's the year technologists have long predicted machines will match… then surpass… human intelligence.

We're the generation caught between those two dates. The old world is still running. The new one is already being assembled.

Close your eyes for a second. Imagine it's 2045. Your doctor hasn't touched a stethoscope in years. An AI designed the pill you take every morning… and another AI diagnosed the condition that required it. Your kid's teacher is a hologram three days a week. The house you live in was printed from recycled concrete in eleven days.

It sounds impossible. But every piece of it is under construction right now.

The FDA has authorized over 1,400 AI-enabled medical devices. Eli Lilly just signed a $2.75 billion deal to bring AI-discovered drugs to market. Digital health startups pulled in $4 billion in a single quarter this year. And 15,000 nurses in New York City walked off the job for 41 days… partly because the machines are already arriving.

We are living in the final stretch of the old world. The last twenty years before everything looks different.

Each issue of 2045 works the same way. First, a letter from someone living in 2045. Fiction. Then we snap back to the present and show you the evidence… the sourced, current data that proves the letter's world is already taking shape. The letter is made up. The data is not.

The Last Scan I Read Alone
A radiologist in Leeds watches his profession dissolve into something he barely recognizes — and wonders if the patients are better off.
 
TRANSMISSION
From: Dr. James Okafor, Leeds, UK
Date: June 2, 2045
Subject: The machine sees what I used to see

Leeds. Early morning.

The imaging suite is quiet at 6 a.m. It always is now.

I used to arrive at this hour to get ahead of the queue. Sixty, seventy scans waiting. Chest X-rays. CT abdomens. The odd brain MRI that made your stomach drop before you even loaded it.

That was the old job. My hands on the mouse. My eyes on the screen. Twenty-five years of training compressed into a split-second feeling… something’s wrong here.

Now I walk in and the screens are already done.

MedSight — that’s what the trust calls the system — reads every scan that comes through Leeds General overnight. By the time I sit down, it’s sorted them. Green means clear. Amber means check. Red means a consultant needs to look. Right now.

I handle the ambers.

Most mornings, there are about thirty. The system is nearly certain they’re fine… but not certain enough. So I open each one. I look. I compare. I confirm or override.

It takes me ninety minutes. The old queue took eleven hours.

Here’s the thing. I should feel relieved. And in some ways I do. The reds get caught faster. The turnaround on a cancer flag used to be seventy-two hours. Now it’s under four. Patients are diagnosed sooner. They start treatment sooner. Some of them are alive because of that gap.

But I’d be lying if I said I don’t miss the craft.

There was something in reading a scan from scratch. Noticing the shadow nobody else saw. The weight of it — you held someone’s future in your interpretation. That feeling is gone. MedSight sees the shadow first. Every time.

My daughter thinks I’m being sentimental. She’s probably right.

She’s a GenPharm coordinator… she manages the AI-designed drugs coming through our regional formulary. Half the medicines on the ward didn’t exist five years ago. They were built by systems like Pharma.AI, tested in simulated trials, approved through the accelerated EU pathway. She doesn’t find any of this strange. She grew up with it.

I didn’t.

I trained at King’s College in 2009. We learned anatomy from cadavers. We read films on lightboxes. My supervisor, Dr. Patil, told me once that a good radiologist reads with his gut before his brain. I’ve never forgotten that.

The machine doesn’t have a gut. But it has six million training images. And it doesn’t get tired at 4 p.m. on a Friday.

The staffing crisis was what tipped it. I watched it happen. After the big NHS restructuring of 2031 — the one that gave AI systems prescriptive authority under clinical governance — we lost about a third of the junior radiologists. They moved into AI oversight, clinical data science, patient navigation. Some left medicine entirely.

But we also gained something.

The GP shortage that had been choking the system for years… it eased. Not because we trained more doctors. Because AI handled the diagnostic bottleneck. Freed up time. Freed up people.

My colleague Sarah used to read mammograms. Hundreds a week. Now she runs the regional breast screening programme. She sees patients face-to-face. She talks to them. She says it’s the first time in twenty years she feels like a doctor instead of a machine.

I think about that a lot.

The old system was breaking. I saw it breaking. We were burning out, leaving early, and the pipeline couldn’t keep up. Something had to give.

I just didn’t expect the change to feel like this. Like watching your own skill become… optional.

Still. I go in every morning. I check the ambers. And some days — maybe one in fifty — I catch something MedSight missed. A hairline fracture behind a rib. A tiny lesion the algorithm marked green.

On those days, I still feel it. The old weight. Maybe that’s enough.

 
— James
Leeds, UK
Former Consultant Diagnostic Radiologist, NHS
Clinical AI Oversight Coordinator, Leeds General Infirmary
 
◉ Snap back to the present
James’s letter is fiction. The forces that create his world are not. Every signal in this transmission is already live… in June 2026.
AI
1,451 AI medical devices
The FDA has now authorized 1,451 AI-enabled medical devices. Seventy-six percent of them are in radiology. In 2015, the agency cleared six. In 2025, it cleared 295. James’s world — where AI reads every scan in the hospital overnight — isn’t a leap. It’s the line we’re already drawing.
The Imaging Wire, FDA — 2026
AI
11-hospital system
In March 2026, the CEO of NYC Health + Hospitals — the largest public hospital system in the United States — told a panel that his 11 hospitals are ready to replace radiologists with AI for primary breast cancer screenings. His reasoning: the technology already outperforms humans on first reads. Researchers pushed back. Hard. But the CEO wasn’t theorizing. He was planning. James’s MedSight system is twenty years downstream from that moment.
Radiology Business, Futurism, Crain’s New York Business — 2026
BIOTECH
$2.75 billion
Eli Lilly signed a deal worth up to $2.75 billion with Hong Kong-based Insilico Medicine to develop AI-discovered drugs. Insilico’s Pharma.AI platform designs molecules from scratch — no human chemist required. The company has 28 AI-designed drugs in its pipeline. Nearly half are already in clinical trials. James’s daughter managing AI-built medications on a hospital ward isn’t a fantasy. The drugs are already being made.
CNBC, BioPharma Dive — 2026
AI
$4B in 90 days
Digital health startups raised $4 billion in venture funding in Q1 2026. That’s a billion more than the same quarter last year. Rock Health, which tracks this data, retired its “AI deal” category this quarter. The reason: AI is now in everything. It’s not a special label anymore. It’s the baseline. The money is flowing fast… and it’s building the world James lives in.
Rock Health, Fierce Healthcare — 2026
LABOR
15,000 nurses / 41 days
In January 2026, 15,000 New York City nurses walked out of Mount Sinai, Montefiore, and NewYork-Presbyterian in the largest nurses’ strike in the city’s history. They stayed out for 41 days in freezing cold. The demands: safe staffing ratios, violence protections, fair benefits. The AAMC projects a physician shortage of up to 86,000 by 2036. The old system is breaking under its own weight. James’s NHS restructuring of 2031 starts here.
Jacobin, AJMC, AAMC — 2026
 
That’s the transmission. The letter is fiction. The machines in it are not. The gap between 2026 and 2045 is shrinking fast… and the people inside the system are already feeling it. See you tomorrow.
Share This Letter →
2045
Letters from the transition · Est. 2026